Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.
Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.
More good news for renal denervation: FDA-approved systems linked to positive long-term data
New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk
The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns.
Patient sues Abbott after early heart valve replacement
The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.

Heart attacks after TAVR: New AMI data ‘reassuring’ at first glance, but questions remain

Hoping to gain a better understanding of how TAVR may impact a patient’s long-term cardiovascular health, researchers explored data from more than 200,000 patients and shared their findings in JACC: Cardiovascular Interventions.

Microplastics in carotid plaques increase risk of adverse cardiovascular outcomes

Polyethylene was present in 58.4% of patients, and polyvinyl chloride was present in 12.1%. The presence of either one was associated with an increased risk of heart attack, stroke or death.

SIR 2024: UAE can eliminate the need for hysterectomy after postpartum hemorrhage

In a study presented at the Society of Interventional Radiology Annual Scientific Meeting, the procedure reduced hysterectomies by 94%.

SIR 2024: Study finds ultrasound ablation to be a precise, effective treatment for prostate cancer

The MRI-guided transurethral ultrasound ablation comes with minimal side effects, offering cancer patients an alternative to radiation or surgery.

artificial intelligence robot evaluates healthcare data

New data registry will track how AI-powered plaque assessments impact cardiologist decisions

HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.

doctor examines patient data on their tablet

Hospital system data sharing initiative leads to 80% of patients accessing their imaging records

The change was made to comply with the information blocking rule in the 21st Century Cures Act.

FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck

Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.

Report: Johnson & Johnson once again considering deal to acquire Shockwave Medical

Healthcare giants Boston Scientific, Johnson & Johnson and Medtronic were all reportedly interested in acquiring Shockwave Medical in 2023. Now, new rumors suggest a deal could be finalized within weeks.

Clinical

Private equity-backed Medline files for IPO

Key takeaways for interventional cardiology from TCT 2025

More good news for renal denervation: FDA-approved systems linked to positive long-term data

Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk

Patient sues Abbott after early heart valve replacement